RECURSION PHARMACEUTICALS, INC. 4

CFO Ben R. Taylor had 25,018 Recursion Pharmaceuticals Class A shares withheld for tax purposes related to RSU settlement at about $3.16 per share.

On August 17, 2026, Recursion Pharmaceuticals, Inc. Chief Financial Officer Ben R. Taylor had 25,018 shares of Class A Common Stock withheld by the company at a price of approximately $3.16 per share, solely to satisfy tax withholding obligations arising from the net settlement of restricted stock units; this non-open-market transaction reduced his holdings to 1,076,858 shares of Class A Common Stock, which remain a substantial stake in the issuer.

Filing Facts

CIK

1601830

Ticker

RXRX

Form

4

Source Type

fda

Accession

0001712276-26-000009

Alert Tier

5